Blue Jet Healthcare Ltd vs Remus Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Blue Jet Healthcare Ltd is ₹ 488.4 as of 06 May 15:30 . The P/E Ratio of Blue Jet Healthcare Ltd is 0 as of March 2021 .The P/E Ratio of Remus Pharmaceuticals Ltd is 0 as of March 2021 . The Market Cap of Blue Jet Healthcare Ltd is ₹ 0 crore as of March 2021 .The Market Cap of Remus Pharmaceuticals Ltd is ₹ 0 crore as of March 2021 . The revenue of Blue Jet Healthcare Ltd for the Dec '25 is ₹ 205.62 crore as compare to the Sep '25 revenue of ₹ 189.75 crore. This represent the growth of 8.36% The revenue of Remus Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Blue Jet Healthcare Ltd for the Dec '25 is ₹ 60.1 crore as compare to the Sep '25 ebitda of ₹ 79.22 crore. This represent the decline of -24.14% The ebitda of Remus Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Blue Jet Healthcare Ltd changed from ₹ 37.78 crore to ₹ 40.17 crore over 7 quarters. This represents a CAGR of 3.57% The net profit of Remus Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Blue Jet Healthcare Ltd changed from 10.59 % on March 2024 to 6.82 % on March 2025 . This represents a CAGR of -19.75% over 2 yearsThe Dividend Payout of Remus Pharmaceuticals Ltd changed from 2.56 % on March 2023 to 4.44 % on March 2025 . This represents a CAGR of 20.15% over 3 years .

About Blue Jet Healthcare Ltd

Blue Jet Healthcare Limited was originally incorporated as Jet Chemicals Private Limited,' at Mumbai, dated December 7, 1968.
The Company name was changed to Blue Jet Healthcare Private Limited', and a fresh Certificate of Incorporation dated December 30, 2020, was issued by the Registrar of Companies, Mumbai.
Subsequently, the status got converted into a Limited Company and its name was changed to Blue Jet Healthcare Limited' on May 18, 2022. The Company is a global, science-led, pharmaceutical company evolved as strategic partner for Collaboration, Development & Manufacturing of Advance Pharmaceutical Intermediates and API. It operate into 3 product categories, contrast media intermediates, high- intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs).

About Remus Pharmaceuticals Ltd

Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat.
Subsequently, Company converted from a Private to Public and the name of the Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad. The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs.
It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries.
The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.

FAQs for the comparison of Blue Jet Healthcare Ltd and Remus Pharmaceuticals Ltd

Which company has a larger market capitalization, Blue Jet Healthcare Ltd or Remus Pharmaceuticals Ltd?

Market cap of Blue Jet Healthcare Ltd is 8,472 Cr while Market cap of Remus Pharmaceuticals Ltd is 843 Cr

What are the key factors driving the stock performance of Blue Jet Healthcare Ltd and Remus Pharmaceuticals Ltd?

The stock performance of Blue Jet Healthcare Ltd and Remus Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Blue Jet Healthcare Ltd and Remus Pharmaceuticals Ltd?

As of May 6, 2026, the Blue Jet Healthcare Ltd stock price is INR ₹488.4. On the other hand, Remus Pharmaceuticals Ltd stock price is INR ₹715.4.

How do dividend payouts of Blue Jet Healthcare Ltd and Remus Pharmaceuticals Ltd compare?

To compare the dividend payouts of Blue Jet Healthcare Ltd and Remus Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.